Sybertz E - Search Results

1

Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.

Fitzpatrick MA, Rademaker MT, Charles CJ, Yandle TG, Espiner EA, Ikram H, Sybertz E. Fitzpatrick MA, et al. Among authors: sybertz e. J Cardiovasc Pharmacol. 1992 Apr;19(4):635-40. doi: 10.1097/00005344-199204000-00022. J Cardiovasc Pharmacol. 1992. PMID: 1380608

2

Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure.

Rademaker MT, Fitzpatrick MA, Charles CJ, Richards AM, Nicholls MG, Espiner EA, Sybertz E. Rademaker MT, et al. Among authors: sybertz e. J Cardiovasc Pharmacol. 1996 Mar;27(3):439-46. doi: 10.1097/00005344-199603000-00018. J Cardiovasc Pharmacol. 1996. PMID: 8907807

3

Low-dose brain natriuretic peptide infusion in normal men and the influence of endopeptidase inhibition.

Florkowski CM, Richards AM, Espiner EA, Yandle TG, Sybertz E, Frampton CM. Florkowski CM, et al. Among authors: sybertz e. Clin Sci (Lond). 1997 Mar;92(3):255-60. doi: 10.1042/cs0920255. Clin Sci (Lond). 1997. PMID: 9093005 Clinical Trial.

4

Endopeptidase inhibition in angiotensin-induced hypertension. Effect of SCH 39370 in sheep.

Charles CJ, Espiner EA, Richards AM, Sybertz EJ. Charles CJ, et al. Among authors: sybertz ej. Hypertension. 1995 Jul;26(1):89-94. doi: 10.1161/01.hyp.26.1.89. Hypertension. 1995. PMID: 7607738

5

Hemodynamic and hormonal effects of neutral endopeptidase inhibitor SCH 39370 in sheep.

Charles CJ, Espiner EA, Cameron VA, Richards AM, Yandle TG, Sybertz EJ. Charles CJ, et al. Among authors: sybertz ej. Hypertension. 1991 May;17(5):643-51. doi: 10.1161/01.hyp.17.5.643. Hypertension. 1991. PMID: 1850715

6

Prolonged neutral endopeptidase inhibition in heart failure.

Helin K, Tikkanen I, Tikkanen T, Saijonmaa O, Sybertz EJ, Vemulapalli S, Sariola H, Fyhrquist F. Helin K, et al. Among authors: sybertz ej. Eur J Pharmacol. 1991 May 30;198(1):23-30. doi: 10.1016/0014-2999(91)90557-7. Eur J Pharmacol. 1991. PMID: 1655477

7

Hemodynamic actions of a synthetic atrial natriuretic factor.

Baum T, Sybertz EJ, Watkins RW, Nelson S, Coleman W, Pula KK, Prioli N, Rivelli M, Grossman A. Baum T, et al. Among authors: sybertz ej. J Cardiovasc Pharmacol. 1986 Sep-Oct;8(5):898-905. doi: 10.1097/00005344-198609000-00003. J Cardiovasc Pharmacol. 1986. PMID: 2429088

8

Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.

Tikkanen I, Helin K, Tikkanen T, Sybertz EJ, Vemulapalli S, Sariola H, Näveri H, Fyhrquist F. Tikkanen I, et al. Among authors: sybertz ej. J Pharmacol Exp Ther. 1990 Aug;254(2):641-5. J Pharmacol Exp Ther. 1990. PMID: 2143536

9

Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor.

Vemulapalli S, Watkins RW, Chintala M, Davis H, Ahn HS, Fawzi A, Tulshian D, Chiu P, Chatterjee M, Lin CC, Sybertz EJ. Vemulapalli S, et al. Among authors: sybertz ej. J Cardiovasc Pharmacol. 1996 Dec;28(6):862-9. doi: 10.1097/00005344-199612000-00018. J Cardiovasc Pharmacol. 1996. PMID: 8961086

10

Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.

Sybertz EJ, Baum T, Ahn HS, Nelson S, Eynon E, Desiderio DM, Pula K, Becker F, Sabin C, Moran R, Vander Vliet G, Kastner B, Smith E. Sybertz EJ, et al. J Cardiovasc Pharmacol. 1983 Jul-Aug;5(4):643-54. doi: 10.1097/00005344-198307000-00021. J Cardiovasc Pharmacol. 1983. PMID: 6193364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters